Premium
Allopurinol induces innate immune responses through mitogen‐activated protein kinase signaling pathways in HL‐60 cells
Author(s) -
Nakajima Akira,
Oda Shingo,
Yokoi Tsuyoshi
Publication year - 2016
Publication title -
journal of applied toxicology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.784
H-Index - 87
eISSN - 1099-1263
pISSN - 0260-437X
DOI - 10.1002/jat.3272
Subject(s) - allopurinol , innate immune system , mapk/erk pathway , immunology , tumor necrosis factor alpha , cytokine , immune system , monocyte , signal transduction , hacat , kinase , microbiology and biotechnology , biology , cancer research , medicine , cell culture , genetics
Allopurinol, an inhibitor of xanthine oxidase, is a frequent cause of severe cutaneous adverse reactions (SCARs) in humans, including drug rash with eosinophilia and systemic symptoms, Stevens–Johnson syndrome and toxic epidermal necrolysis. Although SCARs have been suspected to be immune‐mediated, the mechanisms of allopurinol‐induced SCARs remain unclear. In this study, we examined whether allopurinol has the ability to induce innate immune responses in vitro using human dendritic cell (DC)‐like cell lines, including HL‐60, THP‐1 and K562, and a human keratinocyte cell line, HaCaT. In this study, we demonstrate that treatment of HL‐60 cells with allopurinol significantly increased the mRNA expression levels of interleukin‐8, monocyte chemotactic protein‐1 and tumor necrosis factor α in a time‐ and concentration‐dependent manner. Furthermore, allopurinol induced the phosphorylation of mitogen‐activated protein kinases (MAPK), such as c‐Jun N‐terminal kinase and extracellular signal‐regulated kinase, which regulate cytokine production in DC. In addition, allopurinol‐induced increases in cytokine expression were inhibited by co‐treatment with the MAPK inhibitors. Collectively, these results suggest that allopurinol has the ability to induce innate immune responses in a DC‐like cell line through activation of the MAPK signaling pathways. These results indicate that innate immune responses induced by allopurinol might be involved in the development of allopurinol‐induced SCARs. Copyright © 2015 John Wiley & Sons, Ltd.